Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction


Related Publications

Suter E, Misfeldt R, Mallinson S, Wilhelm A, Boakye O, Marchildon G, et al. Comparative Review of the Policy Landscape of Team-based Primary Health Care Service Delivery in Western Canada. Alberta Health Services; 2014.
Laberge M, Pang J, Walker K, Wong ST, Hogg W, Wodchis WP. QUALICOPC (Quality and Costs of Primary Care) Canada: A focus on the aspects of primary care most highly rated by current patients of primary care practices. Ottawa, ON: Canadian Foundation for Healthcare Improvement; 2014.
McGregor MJ, Abu-Laban RB, Ronald L, McGrail KM, Andrusiek D, Baumbusch J, et al. Nursing Home Characteristics Associated with Resident Transfers to Emergency Department. Canadian Journal on Aging. 2012;33(1):38-48.
Koehoorn M, McLeod CB, Fan JK, McGrail KM, Barer ML, Cote P, et al. Do private clinics or expedited fees improve wait- or return-to-work times for injured workers following knee surgery? Healthcare Policy. 2011;5(3):17-26.
Sutherland JM, Barer ML, Evans RG, Crump RT. Will paying the piper change the tune? Healthcare Policy. 2011;6(4):16-24.

Publication Topics

Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction

Publication TypeJournal Article
Year of Publication2011
AuthorsHanley GE, Morgan SG, Reid RJ
JournalJournal of General Internal Medicine
Pages1329 - 1335
Date Published2011
KeywordsAdrenergic beta-Antagonists/therapeutic use, Adult, Age Factors, Aged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, British Columbia, Confidence Intervals, Cross-Sectional Studies, Evidence-Based Medicine/economics/statistics & numerical data, Female, Health Status Disparities, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Income/statistics & numerical data, Male, Middle Aged, Myocardial Infarction/drug therapy/economics, Odds Ratio, Sex Factors, Social Class
AbstractBACKGROUND: Previous research has shown a socioeconomic status (SES) gradient in the receipt of cardiac services following acute myocardial infarction (AMI), but much less is known about SES and the use of secondary preventive medicines following AMI. OBJECTIVES: To examine the role of income in initiation of treatment with ACE-inhibitors, beta-blockers and statins in the 120 days following discharge from hospital for first AMI. DESIGN: A cross-sectional study with a population-based cohort. PARTICIPANTS: First-time AMI patients between age 40 and 100 discharged alive from the hospital and surviving at least 120 days following discharge between January 1, 1999 and September 3, 2006. MAIN MEASURES: Binary variables indicating whether the patient had filled at least one prescription for each of the medicines of interest. KEY RESULTS: Our results reveal a significant and positive income gradient with initiation of the guideline-recommended medicines among male AMI patients. Men in the third income quintile and above were significantly more likely to initiate treatment with any of the medicines than those in the first quintile, with those in the fifth income quintile having 37%, 50% and 71% higher odds of initiating ACE-inhibitors, beta-blockers and statins, respectively, than men in the lowest income quintile [OR = 1.37 95% CI (1.24, 1.51); OR = 1.50 95% CI (1.35, 1.68); and OR = 1.71 95% CI (1.53, 190)]. The gradient was not present among women, although women in the fifth income quintile were more likely to initiate beta-blockers and statins than women in the lowest income quintile [OR = 1.25 95% CI (1.06, 1.47) and OR = 1.32 95% CI (1.12, 1.54)]. CONCLUSIONS: There were inequities in treatment following AMI in the form of a clear and often significant gradient between income and initiation of evidence-based pharmacologic therapies among male patients. This gradient persisted despite significant changes in coverage levels for the costs of these medicines.
Citation Key365